WSJ News Exclusive | Nonprofit Health Plans With $6.8 Billion in Projected Revenue Set to Combine

[ad_1] WSJ News Exclusive Health Insurers SCAN Group and CareOregon would form HealthRight, covering Medicare and Medicaid enrollees [ad_2] Source link

In Chinese Protests’ Aftermath, Some People Could Face Criminal Charges

[ad_1] World Asia China Several protesters remain in detention, according to people familiar with their situation [ad_2] Source link

Pandemic Loans Are Coming Due but Some Businesses Aren’t Ready to Repay

[ad_1] Borrowers grapple with a slower-than-expected rebound and new economic challenges. [ad_2] Source link

Fentanyl Awareness Campaign Urges Parents to ‘Drop the F-Bomb’ With Their Kids

[ad_1] A new campaign from the Ad Council and Meta Platforms Inc. is encouraging parents of teen and young-adult children to speak to them about the dangers of fentanyl. Drug…

Moderna’s mRNA Cancer Vaccine Shows Promise in Preliminary Study

[ad_1] Business Health Care Health The shot combined with a Merck immunotherapy reduced the risk of relapse in people with skin cancer in a study, Moderna said [ad_2] Source link

China’s Zero-Covid Policy Is Ending, but Not Everyone Is Celebrating

[ad_1] HONG KONG—After three years of trying to keep Covid-19 at bay, China is finally loosening its draconian zero-Covid rules. But instead of celebrating, many people are hunkering down, cutting…

Opinion | Oregon’s Socialized Healthcare by Lawsuit

[ad_1] Voters pass a legally enforceable version of Medicare for All. They will soon pay for it. [ad_2] Source link

Opinion | The Exaggeration of Long Covid

[ad_1] Lingering symptoms after a respiratory infection are common. Most cases are too mild to worry about. [ad_2] Source link

Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis

[ad_1] Clovis Oncology Inc., maker of the ovarian and prostate cancer drug Rubraca, filed for bankruptcy over the weekend with a proposed deal in hand to sell its rights to…

First Test for Amgen: Fix Horizon’s Growth Problem

[ad_1] Markets Heard on the Street Sales of Horizon’s thyroid-eye disease drug Tepezza have plateaued, a challenge its new owner will need to contend with [ad_2] Source link